Despite correlative clinical evidence linking PKCδ to AD and the observations that PKCδ inhibition can attenuate Aβ production in animal models [10], whether PKCδ directly contributes to Aβ neurotoxicity remains to be determined. The gene discussed is PRKCD; the disease is Alzheimer disease.